The Patent Finder

Protagonist Therapeutics, Inc.

Also on record
Records under this name other than the patents Protagonist Therapeutics, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 28 patents it holds.

Showing 1 to 8 of 8 · Back to Protagonist Therapeutics, Inc.

PatentTitleStatus Expires Confidence
US 9,714,270a4B7 integrin thioether peptide antagonists
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,059,744α4β7 thioether peptide dimer antagonists
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,626,146α4β7 thioether peptide dimer antagonists
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 11,840,581α4β7 thioether peptide dimer antagonists
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,407,468Methods for synthesizing α4β7 peptide antagonists
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 11,845,808Peptide Inhibitors of INTERLEUKIN-23 Receptor and Their Use to Treat Inflammatory Diseases
Formerly held
In force
 · High confidence
In forceHigh confidence
US 12,018,057Peptide Inhibitors of INTERLEUKIN-23 Receptor and Their Use to Treat Inflammatory Diseases
Formerly held
In force
 · High confidence
In forceHigh confidence
US 12,478,617Lipidated Peptide Inhibitors of INTERLEUKIN-23 Receptor
Formerly held
In force
 · High confidence
In forceHigh confidence
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited